Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“Regulators considered overhauling sampling rules to require lab personnel to collect samples but withdrew the proposal after manufacturers opposed it.”
VerifiedConfidence: HIGH

Reasoning

The claim is directly supported by the provided evidence: the article reports that regulators were considering an overhaul of sampling rules to require lab personnel to collect samples, but withdrew the proposal after top manufacturers argued it would be too costly.

On confidence: Multiple excerpts from the same ProPublica article directly state that regulators considered changing sampling rules to require lab personnel to collect samples and then backed down after manufacturers opposed the proposal.

Important context

The withdrawal was due to cost concerns raised by manufacturers, not necessarily other factors. The evidence comes from a single investigative report, but it explicitly addresses both parts of the claim.

Evidence

Supporting (3)

Limitations

All evidence comes from one source (ProPublica). No additional independent sources are provided to corroborate the information.

Last verified:
Sep 27, 2026, 4:21 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Colorado Marijuana Company Voluntarily Recalls Dozens of Contaminated Products Amid State Regulatory Delays

ProPublica · Christopher Osher